Logo (Merck) 351 Pill - yellow oval
Generic Name: vorapaxar
Pill with imprint Logo (Merck) 351 is Yellow, Oval and has been identified as Zontivity vorapaxar sulfate 2.5 mg (2.08 mg base). It is supplied by Merck Sharp & Dohme Corp.
Zontivity is used in the treatment of Peripheral Arterial Disease; Prevention of Atherothrombotic Events; Thromboembolic Disorder and belongs to the drug class protease-activated receptor-1 antagonists. There is no proven risk in humans during pregnancy. Zontivity vorapaxar sulfate 2.5 mg (2.08 mg base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo (Merck) 351
Zontivity
- Generic Name
- vorapaxar
- Imprint
- Logo (Merck) 351
- Strength
- vorapaxar sulfate 2.5 mg (2.08 mg base)
- Color
- Yellow
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Protease-activated receptor-1 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck Sharp & Dohme Corp.
- National Drug Code (NDC)
- 00006-0351 (Discontinued)
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
croscarmellose sodium,
povidone,
magnesium stearate,
hypromellose 2910 (15 mPa.s),
titanium dioxide,
triacetin,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about Zontivity (vorapaxar)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: protease-activated receptor-1 antagonists
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
